Relief Therapeutics Holding SA (SWX:RLF)
Switzerland
· Delayed Price · Currency is CHF
2.790
0.00 (0.00%)
At close: Dec 5, 2025
SWX:RLF Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 35 | 53 | 25 | 132 | 274 | 873 | |
| Market Cap Growth | -39.36% | 111.56% | -81.09% | -51.90% | -68.59% | 41215.19% | |
| Enterprise Value | 25 | 44 | 17 | 106 | 263 | 874 | |
| Last Close Price | 2.79 | 4.21 | 1.99 | 12.00 | 24.88 | 107.60 | |
| PS Ratio | 8.67 | 6.27 | 4.14 | 21.70 | 82.61 | - | |
| PB Ratio | 1.08 | 1.44 | 0.48 | 0.91 | 1.51 | 13.03 | |
| P/TBV Ratio | 17.07 | 9.36 | - | - | - | 24.10 | |
| EV/Sales Ratio | 6.05 | 5.29 | 2.77 | 17.46 | 79.33 | - | |
| Debt / Equity Ratio | 0.06 | 0.06 | 0.08 | 0.03 | 0.02 | 0.01 | |
| Asset Turnover | - | 0.13 | 0.05 | 0.03 | 0.02 | - | |
| Inventory Turnover | - | 3.22 | 4.90 | 4.05 | 3.84 | - | |
| Quick Ratio | 3.72 | 3.43 | 2.52 | 2.01 | 2.41 | 5.73 | |
| Current Ratio | 4.05 | 3.95 | 2.65 | 2.11 | 2.79 | 7.00 | |
| Return on Equity (ROE) | - | -38.52% | -99.35% | -31.07% | -27.92% | -19.25% | |
| Return on Assets (ROA) | - | -7.35% | -9.36% | -9.92% | -12.98% | -24.72% | |
| Return on Capital (ROIC) | - | -9.99% | -12.03% | -13.02% | -16.87% | -28.82% | |
| Return on Capital Employed (ROCE) | -18.50% | -15.80% | -28.60% | -19.60% | -14.80% | -27.10% | |
| Earnings Yield | -48.50% | -32.42% | -393.43% | -38.49% | -12.65% | -0.90% | |
| FCF Yield | -10.07% | -5.55% | -72.36% | -18.31% | -13.02% | -2.09% | |
| Buyback Yield / Dilution | -0.52% | -6.71% | -11.18% | -17.67% | -48.89% | -14.70% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.